Ehlers-Danlos syndrome type IV (EDS IV) is the most severe of a heterogeneous group of disorders and is usually inherited in an autosomal dominant manner. ' Affected patients lack or have reduced amounts of type III collagen in their skin.2 Their cultured skin fibroblasts also secrete a reduced amount of this molecule, mostly retaining the mutant form intracellularly.3 A number of mutations in the gene (COL3Al) encoding this protein have been found, which include the substitution of glycine residues. 4 The presence of a glycine at every third amino acid is a prerequisite for the formation of a stable collagen helix. Thus the substitution of a glycine in one of these positions can destabilise the helix and delay its formation, causing excessive post-translational modification N-terminal to the point of the substitution. Analysis of such overmodification has proved useful in mapping the site of single amino acid mutations in collagen molecules. 56 In type III collagen these amino acid substitutions have produced various effects on the stability of the molecule as judged by thermal induction of helix to coil transition. These effects range from a 2 to 4 
lularly. This was consistent with an overmodified form of the protein caused by a mutation being present. These two species of type III collagen were excised from the gel, cleaved in * (X1(I) situ with cyanogen bromide, and then sub- 
Discussion
The proband described here has the most Nterminal glycine substitution so far described in a patient with Ehlers-Danlos syndrome type IV. Only the Gly 619's and 13616 to Arg substitutions in patients with aortic aneurysms are more N-terminal. The Arg 619 substitution did not affect the thermal stability of the secreted type III collagen, but a reduced thermal stability was detected when the collagenase A fragment was analysed. The secreted form of the mutant Arg 661 substitution described here also has normal thermal stability. Thus, a correlation between thermal stability of these pepsin resistant triple helixes and secretion does not appear to exist. The difference, seen here, between the secreted and retained form of the mutant protein indicates that molecules resulting from the same mutation can differ in their thermal stabilities. This is perhaps not surprising since type III collagen is a trimeric molecule and mutant forms consisting of either one, two, or three abnormal chains will exist, as will the normal product. Presumably this variable composition leads to the differences seen in thermal stability. An alternative explanation for our observations is that some normal homotrimers of type III collagen from these cells are overmodified and secreted into the medium. However, we think this is unlikely because of the asymmetrical distribution of overmodification, which is seen only in and Nterminal of CB5 and does not affect CB9. This is consistent with the arginine substitution being present in these molecules. As yet we have no data to suggest which particular trimer composition is the more stable. In summary the proband described here has a new dominant mutation which converts glycine 661 in type III collagen to arginine. This results in two forms of mutant protein. One is secreted and has normal thermal stability, whereas the other is retained intracellularly and melts abnormally between 37'C and 38°C.
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